• No results found

University of Groningen Melanoma Damude, Samantha

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Melanoma Damude, Samantha"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Melanoma

Damude, Samantha

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Damude, S. (2018). Melanoma: New Insights in Follow-up & Staging. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

m e l a

n o m

a

S . Da m u d e

new insights

in follow-up

and staging

(3)

colofon

Cover Design Robert Souhuwat Samantha Damude Layout

Fleur Bominaar, FYN Werk www.fynwerk.nl Printed by Gildeprint, Enschede www.gildeprint.nl ISBN: 978-94-9301-486-2 (book) ISBN: 978-94-9301-492-3 (ebook) © 2018 S. Damude, The Netherlands

All rights reserved. No part of this book may be reproduced, stored in a retreival system or transmitted in any form or by any means, without prior permission of the author.

Support

The research described in this thesis was financially supported by a grant from the Groningen Melanoma Sarcoma Foundation.

Financial support for printing this thesis was kindly provided by the University Medical Center Groningen (UMCG) Department of Surgical Oncology, the Graduate School of Medical Sciences Groningen (GSMS), Maatschap Chirurgie Treant Zorggroep, Noord Negentig Accountants en Belastingadviseurs, Ekster Vintage, Bodyform Waterbedden & Tribrid Air Matrassen, Mediflow Orthopedische Waterkern Kussens.

(4)

MELANOMA

New Insights in Follow-up & Staging

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken

en volgens besluit van het College voor Promoties. De openbare verdediging zal plaatsvinden op woensdag 28 november 2018 om 12.45 uur

door

SAMANTHA DAMUDE

geboren op 16 maart 1986

(5)

PROMOTOR

Prof. dr. H.J. Hoekstra

COPROMOTORES

Dr. J.E.H.M. Hoekstra-Weebers Dr. K.P. Wevers

BEOORDELINGSCOMMISSIE

Prof. dr. I.H.M. Borel Rinkes Prof. dr. H.B.M. van de Wiel Prof. dr. M.F. Jonkman

(6)

Paranimfen

E.M. Coppen M. Faut

(7)
(8)

TABLE OF CONTENTS

1.

General Introduction and Outline of the Thesis 9

PART I.

FOLLOW-UP IN AJCC STAGE I-II MELANOMA

2.

The MELFO-study: Prospective Randomized Clinical Trial for 27 the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients - Results after One Year

3.

Melanoma Patients’ Disease-specific Knowledge, Information 47 Preference, and Appreciation of Educational YouTube Videos

for Self-inspection

4.

Practice Variation in Sentinel Lymph Node Biopsy for Melanoma 67 Patients in Different Geographical Regions in the Netherlands

PART II.

PREDICTION OF NODAL STATUS IN COMPLETION LYPMH NODE DISSECTION USING THE BIOMARKER S-100B

5.

The Predictive Power of Serum S-100B for Non-sentinel Node 89 Positivity in Melanoma Patients

6.

A Prediction Tool Incorporating the Biomarker S-100B for 107 Patient Selection for Completion Lymph Node Dissection

in Stage III Melanoma

PART III.

ACCURATE DETERMINATION OF THE BIOMARKER S-100B

7.

Adipocytes in Venipunctures Cause Falsely Elevated S-100B 129 Serum Values

8.

Double Venipuncture is not Required for Adequate S-100B 137 Determination in Melanoma Patients

9.

Summary & Dutch Summary 157

10.

Future Perspectives 171

A.

APPENDICES

List of Publications & Presentations 188

Authors & Affiliations 190

Acknowledgements - Dankwoord 192

(9)

8

1

3

4

5

6

7

8

9

A

Referenties

GERELATEERDE DOCUMENTEN

Financial support for this study was kindly given by the University Medical Center Groningen.. Printing of this thesis was financially supported by the University Medical Center

Financial support for the publication of this dissertation was kindly provided by research institute SHARE, University Medical Center Groningen, and University of Groningen.

The studies in this thesis address differences in follow-up schedules and the possible implementation of a reduced follow- up surveillance schedule, practice variances

In conclusion, stage-adjusted reduced follow-up surveillance for AJCC stage IB-II melanoma patients does not appear to adversely affect patients’ mental well-being and the

Provided that the quality is guaranteed and recognizable for patients, e-Health videos may additionally contribute to patients’ melanoma-specific knowledge, provide information

These findings of a lower odds to receive SLNB for female patients, older patients and patients with a melanoma located in the head and neck area, was also

Characteristics of the patient (age and gender), primary melanoma (site, histologic type, Breslow thickness, Clark level, ulceration, mitotic rate,

Minitub: Pro- spective registry on Sentinel Node (SN) positive melanoma patients with minimal SN tumor burden who undergo Completion Lymph Node Dissections (CLND) or